GlassScriptPhysician profile
Ghassan Hammoud
NPI 1205806882
$2,192.00
in general payments reported to CMS, 2019-2025
9 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.79 · 2021: $82.93 · 2022: $86.78 · 2023: $32.31 · 2024: $1,688 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,639 · Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,638.92 |
| Food and Beverage | $354.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,807.27 | 2022-2024 | Endoflip |
| Cook Medical LLC | $107.68 | 2020-2021 | |
| Lumendi LLC | $85.95 | 2025 | |
| Erbe USA INC | $85.05 | 2025 | Vio3 |
| Boston Scientific Corporation | $71.56 | 2025 | Exalt Model D |
| Genzyme Corporation | $16.99 | 2025 | |
| Phathom Pharmaceuticals, INC. | $13.46 | 2025 | Voquezna |
| Ambu INC. | $4.04 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghassan Hammoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.